XML 22 R9.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES              
Net income $ 14,870 $ (272) $ 7,204 $ 6,768 $ 26,246 $ 25,251  
Adjustments to reconcile net income to net cash provided by operating activities:              
Gain on sales of loans originated for sale         (3,893) (194)  
Earnings on investment in bank-owned life insurance (651)   (503)   (1,858) (1,473)  
Gain on life insurance proceeds 0   0   (285) 0  
Gain on sales or calls of securities 0   0   (22) (69)  
Gain on equity securities (9)   (28)   (26) (19)  
Restricted stock compensation expense         1,189 1,019  
Depreciation and amortization         4,976 2,268  
Provision for (reversal of) credit losses and unfunded commitments         4,177 (3,056)  
Net amortization of investment securities premiums         960 1,300  
Decrease in interest receivable         351 93  
(Decrease) increase in interest payable         (661) 737  
Mortgage loans originated for sale         (137,252) (9,010)  
Proceeds from sales of loans originated for sale         137,233 8,404  
Decrease in other assets         313 10,954  
Decrease (increase) in deferred tax asset         6,807 (4,144)  
Increase in other liabilities         2,633 2,015  
Net Cash Provided by Operating Activities         40,888 34,076  
CASH FLOWS FROM INVESTING ACTIVITIES              
Proceeds from calls/maturities of investment securities held to maturity         1,503 554  
Proceeds from calls/maturities of investment securities available for sale         40,767 31,783  
Proceeds from sales of investment securities available for sale         98,272 14,336  
Purchase of investment securities available for sale         (93,632) 0  
Purchase of restricted investment in bank stocks         (286) (1,176)  
Net increase in loans         (5,473) (49,193)  
Net cash and cash equivalents received from acquisition         36,206 0  
Net capital expenditures         (904) (587)  
Net Cash Provided by (Used in) Investing Activities         76,453 (4,283)  
CASH FLOWS FROM FINANCING ACTIVITIES              
Net increase (decrease) in noninterest-bearing deposits         19,822 (36,831)  
Net decrease in interest-bearing deposits         (87,935) (33,665)  
Net increase (decrease) in short-term borrowings         64,642 (19,113)  
Proceeds from long-term borrowings         0 60,000  
Repayments on long-term borrowings         (40,188) 0  
Dividends paid         (10,460) (7,990)  
Common stock repurchased         (8,672) (249)  
Common stock issued, net of restricted stock forfeitures and withheld for taxes         327 189  
Net Cash Used in Financing Activities         (62,464) (37,659)  
Net Increase (Decrease) in Cash and Cash Equivalents         54,877 (7,866)  
CASH AND CASH EQUIVALENTS — BEGINNING   $ 47,262   $ 65,958 47,262 65,958 $ 65,958
CASH AND CASH EQUIVALENTS — ENDING $ 102,139   $ 58,092   102,139 58,092 $ 47,262
Supplemental disclosures of cash flow information              
Cash paid for interest         29,365 16,848  
Cash paid for income taxes         1,941 4,175  
Supplemental disclosures of certain noncash activities:              
Recognition of Operating Lease Right of Use Assets, Noncash         729 0  
Recognition of operating lease liabilities, noncash         729 0  
Premises And Equipment, Net Transferred To Assets Held For Sale         275 0  
Fair Value of Assets Acquired         877,557 0  
Liabilities Assumed         793,908 0  
Common shares issued         $ 83,649 $ 0  
Common stock shares repurchased (in shares) (61,586)